Primary Outcome Measures:
- Feasibility [ Time Frame: Up to 10 days ]
patient is unable to complete all of his/her treatments with 10 days of estimated date of treatment completion or requires a treatment breaks greater than 5 days.
- Acute Toxicity [ Time Frame: 90 days ]
Any grade 3 or higher toxicty observed within 90 days from start of therapy.
Secondary Outcome Measures:
This trial will be conducted in two phases: a feasibility then a phase II trial. Once feasibility and safety are established in the first 12 pts. the phase II study will begin. Proton therapy at standard doses is not known to improve clinical outcome but will likely reduce fatigue and toxicity.